Pathogenic variants in the COL2A1 gene lead to a series of diseases collectively referred to as type II collagenopathies, which are characterized by skeletal dysplasia (Stickler et al., 2001; Barat-Houari et al., 2016). The gene discussed is COL2A1; the disease is skeletal dysplasia.